| 摘要 |
PROBLEM TO BE SOLVED: To provide an injectable pharmaceutical product comprising an agent, the agent comprising an insoluble carrier to which is bound a peptide, and the peptide being capable of binding fibrinogen such that the agent binds via the bound fibrinogen to activated platelets in preference to inactive platelets wherein the peptide is not fibrinogen. SOLUTION: The present invention relates to platelet substitutes (also called synthetic or artificial platelets) that are useful for treating patients with deficiencies in their own platelets, such as hereditary or acquired defects of platelet numbers (thrombocytopenia) or function (thrombasthenia). COPYRIGHT: (C)2011,JPO&INPIT
|
